在患有上部胃肠道和直肠癌的患者的新辅助疗法期间的预康复 - 研究协议
Irina Chmelova1,2, Dalibor Pastucha1,2, Tomas Hudecek1
1Department of Rehabilitation and Sports Medicine, University Hospital Ostrava, Ostrava, Czechia.
这项研究探讨了对接受新辅助治疗的患者进行体育训练的家庭预康复计划的可行性. 该计划旨在改善患者在手术前的结果.
科学领域:
- 在瘤学瘤学.
- 康复医学 康复医学 康复医学
- 临床试验 临床试验
背景情况:
- 预康复干预措施在手术等生理压力因素之前提高了患者的功能能力.
- 新辅助化疗 (放射性疗法) 之前的手术程序,为预康复提供了一个机会.
- 术后发病率和死亡率的降低是预康复的潜在好处.
研究的目的:
- 评估接受新辅助治疗的患者预康复计划的可行性.
- 评估患者参与和遵守家庭体育训练方案.
- 收集有关预康复对健康和生活质量影响的初步数据.
主要方法:
- 一个干预性可行性研究设计,只用一个小组.
- 在家进行体育训练,包括渐进步行和力量炼.
- 患者数据的远程测量和电话监控.
- 评估主要结果:参与率,完成率和合规性.
- 二次结果的评估:心肺运动测试,握力,身体组成和生活质量调查问卷.
主要成果:
- 将收集有关患者兴趣,计划完成和合规性的可行性数据.
- 将分析身体健康参数,身体组成和生活质量的变化.
- 将两组诊断患者之间的结果进行比较.
结论:
- 这些发现将有助于设计更大规模的,多中心的,对预康复的受控研究.
- 这项研究为优化瘤患者预康复策略提供了基础.
更多相关视频
10:31Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
